• Study on the Effectiveness and Safety of Lenvatinib, Pembrolizumab, and Chemotherapy for Patients with Advanced or Metastatic Gastroesophageal Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Ireland Italy Poland +1
  • Study of Pembrolizumab, MK-4830, and Chemotherapy for Patients with High-Grade Serous Ovarian Cancer

    Not recruiting

    2 1 1 1
    Belgium Italy Poland Spain
  • Study on Briquilimab for Adults with Chronic Inducible Urticaria Unresponsive to H1-Antihistamines

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Germany
  • Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    France Italy Poland Spain
  • Study of Pembrolizumab and Enzalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Denmark Ireland Poland
  • Study of Pembrolizumab with Drug Combination for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Hungary Italy Poland Spain
  • Study of Tirzepatide and Placebo for People with Overweight or Obesity and Chronic Kidney Disease, with or without Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Denmark The Netherlands
  • Study on the Effects of EP262 for Adults with Chronic Spontaneous Urticaria

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany The Netherlands Poland Spain
  • Study on Pembrolizumab and Lenvatinib for Patients with Pre-Treated Thymic Carcinoma and B3-Thymoma

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Spain
  • Study of Venetoclax and Azacitidine for Patients with Acute Myeloid Leukemia After Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Greece Hungary Italy +1

powered by